Donaldson Capital Management, LLC Abbott Laboratories Transaction History

Donaldson Capital Management, LLC

$2.59 Billion
Q3 2024

A detailed history of Donaldson Capital Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Donaldson Capital Management, LLC holds 25,600 shares of ABT stock, worth $2.9 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

25,600

Previous 28,249 9.38%

Holding current value

$2.9 Million

Previous $2.94 Million 0.58%

% of portfolio

0.11%

Previous 0.12%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$100.07 - $118.13 $265,085 - $312,926	-2,649 Reduced 9.38%	25,600 $2.92 Million
Q2 2024 Jul 31, 2024	SELL	$100.73 - $112.44 $2.63 Million - $2.94 Million	-26,113 Reduced 48.04%	28,249 $2.94 Million
Q1 2024 Apr 22, 2024	BUY	$109.52 - $120.96 $876 - $967	8 Added 0.01%	54,362 $6.18 Million
Q4 2023 Jan 30, 2024	SELL	$90.19 - $110.4 $331,358 - $405,609	-3,674 Reduced 6.33%	54,354 $5.98 Million
Q3 2023 Oct 11, 2023	SELL	$95.53 - $114.62 $163,165 - $195,770	-1,708 Reduced 2.86%	58,028 $5.62 Million
Q2 2023 Jul 17, 2023	SELL	$100.78 - $112.29 $518,109 - $577,282	-5,141 Reduced 7.92%	59,736 $6.51 Million
Q1 2023 Apr 13, 2023	BUY	$96.86 - $114.01 $4,649 - $5,472	48 Added 0.07%	64,877 $6.57 Million
Q4 2022 Feb 08, 2023	BUY	$95.06 - $111.52 $226,718 - $265,975	2,385 Added 3.82%	64,829 $7.12 Million
Q3 2022 Oct 13, 2022	SELL	$96.76 - $112.03 $1.89 Million - $2.19 Million	-19,567 Reduced 23.86%	62,444 $6.04 Million
Q2 2022 Aug 11, 2022	SELL	$102.07 - $123.37 $240,885 - $291,153	-2,360 Reduced 2.8%	82,011 $8.91 Million
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $167,723 - $204,527	-1,471 Reduced 1.71%	84,371 $9.99 Million
Q4 2021 Jan 21, 2022	BUY	$115.53 - $141.46 $60,075 - $73,559	520 Added 0.61%	85,842 $12.1 Million
Q3 2021 Nov 04, 2021	BUY	$116.66 - $129.06 $73,029 - $80,791	626 Added 0.74%	85,322 $10.1 Million
Q2 2021 Jul 28, 2021	SELL	$105.79 - $124.53 $430,142 - $506,338	-4,066 Reduced 4.58%	84,696 $9.82 Million
Q1 2021 May 05, 2021	SELL	$108.84 - $128.23 $49,195 - $57,959	-452 Reduced 0.51%	88,762 $10.6 Million
Q4 2020 Jan 11, 2021	BUY	$105.0 - $114.42 $17,220 - $18,764	164 Added 0.18%	89,214 $9.77 Million
Q3 2020 Nov 02, 2020	BUY	$91.64 - $111.29 $387,912 - $471,090	4,233 Added 4.99%	89,050 $9.69 Million
Q2 2020 Jul 27, 2020	SELL	$76.57 - $98.0 $8,958 - $11,466	-117 Reduced 0.14%	84,817 $7.76 Million
Q1 2020 Apr 16, 2020	BUY	$62.82 - $91.86 $455,005 - $665,341	7,243 Added 9.32%	84,934 $6.7 Million
Q4 2019 Jan 14, 2020	BUY	$78.51 - $87.4 $1.84 Million - $2.05 Million	23,419 Added 43.15%	77,691 $6.75 Million
Q3 2019 Nov 04, 2019	BUY	$81.84 - $88.74 $176,365 - $191,234	2,155 Added 4.13%	54,272 $4.54 Million
Q2 2019 Aug 12, 2019	SELL	$72.88 - $85.0 $99,262 - $115,770	-1,362 Reduced 2.55%	52,117 $4.38 Million
Q1 2019 Apr 01, 2019	SELL	$66.22 - $80.06 $428,642 - $518,228	-6,473 Reduced 10.8%	53,479 $4.28 Million
Q4 2018 Feb 08, 2019	SELL	$65.56 - $74.27 $98,012 - $111,033	-1,495 Reduced 2.43%	59,952 $4.34 Million
Q3 2018 Nov 06, 2018	SELL	$60.81 - $73.36 $85,742 - $103,437	-1,410 Reduced 2.24%	61,447 $4.51 Million
Q2 2018 Aug 07, 2018	SELL	$57.57 - $63.54 $239,894 - $264,771	-4,167 Reduced 6.22%	62,857 $3.83 Million
Q1 2018 Apr 30, 2018	SELL	$56.27 - $63.62 $202,853 - $229,350	-3,605 Reduced 5.1%	67,024 $4.02 Million
Q4 2017 Jan 30, 2018	BUY	$53.68 - $57.47 $3.79 Million - $4.06 Million	70,629 New	70,629 $4.03 Million
Q4 2017 Jan 26, 2018	SELL	$53.68 - $57.47 $3.84 Million - $4.11 Million	-71,527 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$48.06 - $53.64 $3.44 Million - $3.84 Million	71,527	71,527 $3.82 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $198B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Donaldson Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Donaldson Capital Management, LLC with notifications on news.

Account

Donaldson Capital Management, LLC Abbott Laboratories Transaction History